Correction to: Demonstration of Physicochemical and Functional Similarity of the Biosimilar BAT1806/BIIB800 to Reference Tocilizumab

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

Extent: 1 Online-Ressource.

Language: Englisch

Bibliographic citation: Correction to: Demonstration of Physicochemical and Functional Similarity of the Biosimilar BAT1806/BIIB800 to Reference Tocilizumab ; volume:38 ; number:5 ; day:22 ; month:8 ; year:2024 ; pages:725 ; date:9.2024
BioDrugs ; 38, Heft 5 (22.8.2024), 725, 9.2024

Creator: Liu, Yujie
Xie, Jianhua
Li, Zhuxiang
Mei, Xiong
Cao, Di
Li, Shengfeng
Engle, Linda
Liu, Suli
Ebbers, Hans C.
Liu, Cuihua

Contributor: SpringerLink (Online service)

DOI: 10.1007/s40259-024-00672-3

URN: urn:nbn:de:101:1-2411132133035.651979395872

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:29 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Liu, Yujie
Xie, Jianhua
Li, Zhuxiang
Mei, Xiong
Cao, Di
Li, Shengfeng
Engle, Linda
Liu, Suli
Ebbers, Hans C.
Liu, Cuihua
SpringerLink (Online service)

Other Objects (12)

Demonstration of Physicochemical and Functional Similarity of the Biosimilar BAT1806/BIIB800 to Reference Tocilizumab

Demonstration of Physicochemical and Functional Similarity of Biosimilar Adalimumab-aqvh to Adalimumab

Demonstration of Physicochemical and Functional Similarity of Biosimilar Pegfilgrastim-cbqv to Pegfilgrastim

Physicochemical and Functional Similarity Assessment Between Proposed Bevacizumab Biosimilar BAT1706 and Reference Bevacizumab

Demonstration of Functional Similarity of Proposed Biosimilar ABP 501 to Adalimumab

Assessing Analytical Similarity of Proposed Amgen Biosimilar ABP 501 to Adalimumab

Physicochemical analysis and biological characterization of FKB327 as a biosimilar to adalimumab

Assessing Analytical and Functional Similarity of Proposed Amgen Biosimilar ABP 980 to Trastuzumab

Analytical and Functional Similarity Assessment of ABP 710, a Biosimilar to Infliximab Reference Product

Quality by Design–Based Assessment for Analytical Similarity of Adalimumab Biosimilar HLX03 to Humira®

Analytical and Functional Similarity of the Biosimilar Candidate ABP 654 to Ustekinumab Reference Product

Biosimilar-to-Biosimilar Switching: What is the Rationale and Current Experience?

Demonstration of Physicochemical and Functional Similarity of the Biosimilar BAT1806/BIIB800 to Reference Tocilizumab

Demonstration of Physicochemical and Functional Similarity of Biosimilar Adalimumab-aqvh to Adalimumab

Demonstration of Physicochemical and Functional Similarity of Biosimilar Pegfilgrastim-cbqv to Pegfilgrastim

Physicochemical and Functional Similarity Assessment Between Proposed Bevacizumab Biosimilar BAT1706 and Reference Bevacizumab

Demonstration of Functional Similarity of Proposed Biosimilar ABP 501 to Adalimumab

Assessing Analytical Similarity of Proposed Amgen Biosimilar ABP 501 to Adalimumab

Physicochemical analysis and biological characterization of FKB327 as a biosimilar to adalimumab

Assessing Analytical and Functional Similarity of Proposed Amgen Biosimilar ABP 980 to Trastuzumab

Analytical and Functional Similarity Assessment of ABP 710, a Biosimilar to Infliximab Reference Product

Quality by Design–Based Assessment for Analytical Similarity of Adalimumab Biosimilar HLX03 to Humira®

Analytical and Functional Similarity of the Biosimilar Candidate ABP 654 to Ustekinumab Reference Product

Biosimilar-to-Biosimilar Switching: What is the Rationale and Current Experience?

Demonstration of Physicochemical and Functional Similarity of the Biosimilar BAT1806/BIIB800 to Reference Tocilizumab

Demonstration of Physicochemical and Functional Similarity of Biosimilar Adalimumab-aqvh to Adalimumab

Demonstration of Physicochemical and Functional Similarity of Biosimilar Pegfilgrastim-cbqv to Pegfilgrastim

Physicochemical and Functional Similarity Assessment Between Proposed Bevacizumab Biosimilar BAT1706 and Reference Bevacizumab

Demonstration of Functional Similarity of Proposed Biosimilar ABP 501 to Adalimumab

Assessing Analytical Similarity of Proposed Amgen Biosimilar ABP 501 to Adalimumab

Physicochemical analysis and biological characterization of FKB327 as a biosimilar to adalimumab

Assessing Analytical and Functional Similarity of Proposed Amgen Biosimilar ABP 980 to Trastuzumab

Analytical and Functional Similarity Assessment of ABP 710, a Biosimilar to Infliximab Reference Product

Quality by Design–Based Assessment for Analytical Similarity of Adalimumab Biosimilar HLX03 to Humira®

Analytical and Functional Similarity of the Biosimilar Candidate ABP 654 to Ustekinumab Reference Product

Biosimilar-to-Biosimilar Switching: What is the Rationale and Current Experience?

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Correction to: Demonstration of Physicochemical and Functional Similarity of the Biosimilar BAT1806/BIIB800 to Reference Tocilizumab

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Demonstration of Physicochemical and Functional Similarity of the Biosimilar BAT1806/BIIB800 to Reference Tocilizumab

Demonstration of Physicochemical and Functional Similarity of Biosimilar Adalimumab-aqvh to Adalimumab

Demonstration of Physicochemical and Functional Similarity of Biosimilar Pegfilgrastim-cbqv to Pegfilgrastim

Physicochemical and Functional Similarity Assessment Between Proposed Bevacizumab Biosimilar BAT1706 and Reference Bevacizumab

Demonstration of Functional Similarity of Proposed Biosimilar ABP 501 to Adalimumab

Assessing Analytical Similarity of Proposed Amgen Biosimilar ABP 501 to Adalimumab

Physicochemical analysis and biological characterization of FKB327 as a biosimilar to adalimumab

Assessing Analytical and Functional Similarity of Proposed Amgen Biosimilar ABP 980 to Trastuzumab

Analytical and Functional Similarity Assessment of ABP 710, a Biosimilar to Infliximab Reference Product

Quality by Design–Based Assessment for Analytical Similarity of Adalimumab Biosimilar HLX03 to Humira®

Analytical and Functional Similarity of the Biosimilar Candidate ABP 654 to Ustekinumab Reference Product

Biosimilar-to-Biosimilar Switching: What is the Rationale and Current Experience?

Demonstration of Physicochemical and Functional Similarity of the Biosimilar BAT1806/BIIB800 to Reference Tocilizumab

Demonstration of Physicochemical and Functional Similarity of Biosimilar Adalimumab-aqvh to Adalimumab

Demonstration of Physicochemical and Functional Similarity of Biosimilar Pegfilgrastim-cbqv to Pegfilgrastim

Physicochemical and Functional Similarity Assessment Between Proposed Bevacizumab Biosimilar BAT1706 and Reference Bevacizumab

Demonstration of Functional Similarity of Proposed Biosimilar ABP 501 to Adalimumab

Assessing Analytical Similarity of Proposed Amgen Biosimilar ABP 501 to Adalimumab

Physicochemical analysis and biological characterization of FKB327 as a biosimilar to adalimumab

Assessing Analytical and Functional Similarity of Proposed Amgen Biosimilar ABP 980 to Trastuzumab

Analytical and Functional Similarity Assessment of ABP 710, a Biosimilar to Infliximab Reference Product

Quality by Design–Based Assessment for Analytical Similarity of Adalimumab Biosimilar HLX03 to Humira®

Analytical and Functional Similarity of the Biosimilar Candidate ABP 654 to Ustekinumab Reference Product

Biosimilar-to-Biosimilar Switching: What is the Rationale and Current Experience?

Demonstration of Physicochemical and Functional Similarity of the Biosimilar BAT1806/BIIB800 to Reference Tocilizumab

Demonstration of Physicochemical and Functional Similarity of Biosimilar Adalimumab-aqvh to Adalimumab

Demonstration of Physicochemical and Functional Similarity of Biosimilar Pegfilgrastim-cbqv to Pegfilgrastim

Physicochemical and Functional Similarity Assessment Between Proposed Bevacizumab Biosimilar BAT1706 and Reference Bevacizumab

Demonstration of Functional Similarity of Proposed Biosimilar ABP 501 to Adalimumab

Assessing Analytical Similarity of Proposed Amgen Biosimilar ABP 501 to Adalimumab

Physicochemical analysis and biological characterization of FKB327 as a biosimilar to adalimumab

Assessing Analytical and Functional Similarity of Proposed Amgen Biosimilar ABP 980 to Trastuzumab

Analytical and Functional Similarity Assessment of ABP 710, a Biosimilar to Infliximab Reference Product

Quality by Design–Based Assessment for Analytical Similarity of Adalimumab Biosimilar HLX03 to Humira®

Analytical and Functional Similarity of the Biosimilar Candidate ABP 654 to Ustekinumab Reference Product

Biosimilar-to-Biosimilar Switching: What is the Rationale and Current Experience?

Related objects

Reset password